Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shelter PharmaBOM:543963 -2.26%66 Interest Coverage is 137.54 as of Mar. 2026, which is 199% above its 10-year median of 46.01. GuruFocus rates BOM:543963 with a GF Score™ of 66/100 and a GF Value™ of ₹57.02 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 684 Drug Manufacturers companies, Shelter Pharma ranks better than 79.53% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Shelter Pharma's
Operating Income
for the
six
months ended in Mar. 2026 was ₹62.4 Mil. Shelter Pharma's Interest Expense for the
six
months ended in Mar. 2026 was ₹-0.5 Mil.
Shelter Pharma's interest coverage for the quarter that ended in Mar. 2026 was 137.54.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Shelter Pharma's Interest Coverage or its related term are showing as below:
BOM:543963'
s Interest Coverage Range Over the Past 10 Years
Min: 4.23 Med: 46.01 Max: 1492
Current: 114.46
BOM:543963's Interest Coverage is ranked better than 79.53% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs BOM:543963: 114.46
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Shelter Pharma Interest Coverage Related Terms
Shelter Pharma Interest Coverage Historical Data
* Premium members only.
The historical data trend for Shelter Pharma's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Shelter Pharma's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shelter Pharma Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shelter Pharma's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Shelter Pharma's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shelter Pharma (BOM:543963) has a Interest Coverage of 137.54 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shelter Pharma and its competitors. This is 199% above median its historical median of 46.01. Over the past decade, Shelter Pharma's Interest Coverage has ranged from 4.23 to 1,492.00. According to the industry distribution chart, Shelter Pharma ranks #140 out of 684 companies in the Drug Manufacturers industry, placing it in the top 20.5%.
Is Shelter Pharma's Interest Coverage too high?
Shelter Pharma's current Interest Coverage of 137.54 is 199% above median its 10-year median of 46.01. Over the past 10 years, this metric has ranged from a low of 4.23 to a high of 1,492.00. The Drug Manufacturers industry median Interest Coverage is 12.77. Shelter Pharma's value of 137.54 is 977.5% above this industry median. Based on the distribution chart, Shelter Pharma ranks #140 out of 684 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Shelter Pharma has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shelter Pharma's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shelter Pharma ranks #140 out of 684 companies for Interest Coverage. This places Shelter Pharma in the top 21% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.77. Shelter Pharma's value of 137.54 is 977.5% above this benchmark. Historically, Shelter Pharma's own Interest Coverage has ranged from 4.23 to 1,492.00 over the past decade. While the company's 10-year median is 46.01 vs. the industry median of 12.77, Shelter Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shelter Pharma's current Interest Coverage of 137.54 is 977.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shelter Pharma and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shelter Pharma's current Interest Coverage is 137.54, which is 199% above median its own 10-year median of 46.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shelter Pharma stock overvalued right now?
Based on GuruFocus' analysis, Shelter Pharma (BOM:543963) is currently considered Possible Value Trap. The stock's GF Value™ is ₹57.02, compared to a current price of ₹26.00 — trading 54.4% below its estimated fair value. The current Interest Coverage is 137.54, which is 199% above median its 10-year median of 46.01 and 977.5% above the Drug Manufacturers industry median of 12.77. Shelter Pharma's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Shelter Pharma (BOM:543963), the current Interest Coverage is 137.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shelter Pharma (BOM:543963) Overvalued in 2026?
Based on GuruFocus' analysis, Shelter Pharma stock appears to be undervalued.
The current stock price of ₹26.00 is trading 54.4% below its estimated GF Value™ of ₹57.02.
GuruFocus considers Shelter Pharma to be Possible Value Trap.
Key valuation signals for BOM:543963:
Interest Coverage: 137.54 (199% above median its 10-year median of 46.01)
GF Value™: ₹57.02 vs. price of ₹26.00 (54.4% below fair value)
Industry Position: 977.5% above the Drug Manufacturers median (#140 of 684)
No single metric tells the full story. See the BOM:543963 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shelter Pharma Ltd focuses in manufacturing herbal products with a well-built presence in Human Pharma as well as the Veterinary space. It is present in majority of the non-critical segments of human and veterinary pharma through its well-spread portfolio. Its products include tablets, syrups, baby drops, barley water, oils, powders, ointments, etc.
66GF Score
Get the complete analysis for BOM:543963
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543963 has been successfully added to your 
